Comprehensive characterization of genomic features and clinical outcomes following targeted therapy and secondary cytoreductive surgery in OCCC: a single center experience.
Silvana Talisa WijayaNatalie Yan Li NgoiJerold Wz LohTuan-Zea TanDiana Gs LimIrfan Sagir KhanYee Liang ThianAlexa LaiBertrand Wl AngPearl Shuang Ye TongJoseph Soon Yau NgJeffrey J H LowArunachalam IlancheranSiew Eng LimYi Wan LimDavid Shao Peng TanPublished in: Journal of gynecologic oncology (2024)
Our study demonstrates encouraging outcomes with bevacizumab and ICI, and SCS in select relapsed OCCC patients. Prospective trials are warranted.